Physician

Mahshid Melody Mosallaei-Benjamin, M.D.

According to 2025 Medicare claims, Mahshid Mosallaei-Benjamin, M.D. (NPI: 1568515138) practices hematology/oncology in the Oxnard-Thousand Oaks-Ventura, CA market, with the plurality of this provider's patient population coming from Ventura, CA. This provider's primary affiliated billing organization is THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (NPI: 1235107566; TIN: 954373071) and primary practice location at 93003-5569. Mosallaei-Benjamin is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Mosallaei-Benjamin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 598 traditional Medicare patients, billed 177,040 HCPCS/CPT codes, and received $3,020,089 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 607 prescription claims across 124 beneficiaries totaling $1,124,243 in drug costs, led by Venclexta (Venetoclax). 2022 DME data shows 47 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $297,440 to $3,020,089. Similarly, Part D prescription costs have risen steadily, from $153,711 to $1,124,243. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	168	18,694	$297,440
2016	136	14,357	$246,524
2017	178	23,885	$485,404
2018	342	58,191	$1,085,161
2019	370	71,795	$1,201,390
2020	458	104,042	$1,742,027
2021	666	171,684	$3,008,366
2022	643	155,864	$2,754,188
2023	632	164,490	$2,889,103
2024	598	177,040	$3,020,089

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	41	132	$153,711
2016	18	117	$68,115
2017	40	151	$151,196
2018	69	338	$216,403
2019	86	401	$404,532
2020	94	516	$977,346
2021	160	704	$817,404
2022	131	596	$1,263,889
2023	131	604	$966,225
2024	124	607	$1,124,243

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	33	$1,786
2017	N/R	48	$2,179
2018	N/R	38	$759
2019	N/R	31	$4,250
2020	N/R	17	$2,668
2021	N/R	79	$4,316
2022	N/R	47	$1,711
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	108	400	$150
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	322	787	$102
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	241	425	$13
36415	Insertion of needle into vein for collection of blood sample	196	439	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	315	953	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Venclexta	Venetoclax	18	526	$195,480
Eliquis	Apixaban	35	1,182	$23,542
Xarelto	Rivaroxaban	11	496	$8,759
Letrozole	Letrozole	90	5,400	$1,548
Anastrozole	Anastrozole	68	4,718	$1,396

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Mahshid Melody Mosallaei-Benjamin, M.D.?

Tedicare shows public-source Medicare data for Mahshid Melody Mosallaei-Benjamin, M.D. (NPI 1568515138), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mahshid Melody Mosallaei-Benjamin, M.D. have ACO affiliation data?

Mahshid Melody Mosallaei-Benjamin, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Mahshid Melody Mosallaei-Benjamin, M.D.?

Mahshid Melody Mosallaei-Benjamin, M.D. is linked to THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (billing NPI 1235107566) in the available physician profile data.

Does Mahshid Melody Mosallaei-Benjamin, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.